Cerus Corporation (NASDAQ:CERS) Jumps Following Clinical update Print E-mail
By Josh Gee   
Monday, 05 January 2015 14:43
 Cerus Corporation (NASDAQ:CERS) shares jumped 4% after the company announced that the haemoglobin content (53.1g) of INTERCEPT content treated red blood cell components (RBCs) on day 35 of storage met the protocol defined criteria for equivalence based on the inferiority margin of 5g as compare to conventional red blood cell components (55.8g). 
Read more...
 
PTC Therapeutics, Inc. (NASDAQ:PTCT) commenced a rolling submission of a New Drug Application Print E-mail
By Marilyn Mullen   
Wednesday, 24 December 2014 10:49
PTC Therapeutics, Inc.(NASDAQ:PTCT) had announced that it has commenced a rolling submission of a New Drug Application to the United States Food and Drug Administration (FDA) for the treatment of nonsense mutation Duchenne muscular dystrophy.
Read more...
 
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Shares Rose High After The Success Of Drug Hep C Print E-mail
By Josh Gee   
Monday, 22 December 2014 20:04
After the biotech reported that the NS5A drug of Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) combined with Gilead's Sovaldi scored a quick cure among a small group of hepatitis C patients after only 6 weeks of treatment, the shares of Achillion rose high.
Read more...
 
Aratana Therapeutics Inc (NASDAQ:PETX) Hits 5-Month High On Positive development Print E-mail
By Marilyn Mullen   
Friday, 19 December 2014 14:05
After the announcement of positive results from the pivotal late-stage field study of its novel drug, AT-001 by Aratana Therapeutics Inc. (NASDAQ:PETX), its stock rose over 26% to $16.50.
Read more...
 
Auspex Pharmaceuticals Inc (NASDAQ:ASPX) Gains Momentum After The Results From Phase Iii Study Print E-mail
By Josh Gee   
Thursday, 18 December 2014 20:28
Shares of Auspex Pharmaceuticals Inc (NASDAQ:ASPX) were doubled on Wednesday and made a new high after the company reported solid  results from phase III study.
Read more...
 
After Merck-Cubist Merger, Is Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) In The Pipeline To Be Acquired? Print E-mail
By Marilyn Mullen   
Monday, 15 December 2014 13:42
Shares of Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH) have gained almost 40% in the past one month and had reached an all time high of $32.93 On December 10, 2014. The stock has been outperforming the broader market on the buyout buzz. 
Read more...
 
Agios Pharmaceuticals Inc (NASDAQ:AGIO) Hits Record Level On Impressive Clinical Data For leukemia drug Print E-mail
By Josh Gee   
Thursday, 20 November 2014 00:54
Shares of Agios Pharmaceuticals Inc. (NASDAQ:AGIO) posted its biggest single day rally on Wednesday since 26th September. The stock is up a whopping 15% to $96.25 after hitting an all time high of $96.88 earlier in the session. More than 2.64 million shares have been traded, compared to its 30-day average volume of 707K shares.
Read more...
 
TapImmune shares gain 28% on pending catalysts and published comments by CEO Print E-mail
By Josh Gee   
Tuesday, 18 November 2014 02:58
icon_marketmoverShares of TapImmune, Inc. (OTCBB:TPIV)  rose nearly 30% on Monday after the firm was mentioned positively by analysts reacting to recently published comments by Chairman & CEO Glynn Wilson, PH.D.
Read more...
 
U.S. Stocks Switched Between Small Gains and Losses Print E-mail
By Josh Gee   
Friday, 07 November 2014 15:22
With the main benchmarks hovering near record levels in the wake of a solid jobs report, a key payrolls data showed the economy added 214,000 jobs in October, while the unemployment rate ticked down to 5.8% — a broadly positive reading.
Read more...
 
U.S. stocks rose on Wednesday, with the Dow Advancing Print E-mail
By Josh Gee   
Wednesday, 05 November 2014 20:36
After the Republican Party took control of the Senate in the midterm elections, as expected, and following a stronger-than-anticipated report on the labor market, some weak earnings in the tech sector capped gains in the Nasdaq, but the beaten-down energy sector rallied on hopes a Republican majority could lead to new legislation that impacts the group.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 10 of 12

Newsletter